Study of Anti-PD-1 Antibody Multimodal Combination as First-line Treatment on Time Window of Advanced Solid Tumor
Clinical trial NCT04282278 · UNKNOWN
Trial details
- NCT number
- NCT04282278
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-16
- Primary completion
- 2022-04-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.